Pediatric Exclusivity Provision - Neonatal Disorders

Relevant Publications

Measuring the patient health, societal and economic benefits of US pediatric therapeutics legislation.

Issue Release: 2012

Pediatric clinical trials in Latin America and Guyana: present views of local practitioners and ways to embrace the future.

Issue Release: 2011

Extrapolation of adult data and other data in pediatric drug-development programs.

Issue Release: 2011

Globalization of pediatric research: analysis of clinical trials completed for pediatric exclusivity.

Issue Release: 2010

The economic returns of pediatric clinical trials of antihypertensive drugs.

Issue Release: 2008

Safety monitoring of drugs granted exclusivity under the Best Pharmaceuticals for Children Act: what the FDA has learned.

Issue Release: 2007

Stimulation programs for pediatric drug research--do children really benefit?

Issue Release: 2007

Effect of the pediatric exclusivity provision on children\'s access to medicines.

Issue Release: 2005

Oral antihypertensive trial design and analysis under the pediatric exclusivity provision.

Issue Release: 2002

How to Choose the Right Cast Protector?

What is Extracorporeal Membrane Oxygenation (ECMO)?

Why is Energy Efficiency Important in Pediatric Care?

What Role Does Data Integration Play?

Why is Rudolph's Pediatrics Important for Pediatricians?

How Important is Multidisciplinary Collaboration?

What are Long Non-Coding RNAs?

How Can Parents Support Vocabulary Development?

What Causes Digestive Disorders in Children?

When Do Babies Typically Start Teething?

Partnered Content Networks

Relevant Topics